脂联素与动脉粥样硬化研究的进展

被引:7
作者
高洁
屈晓冰
机构
[1] 中南大学湘雅二医院
基金
湖南省自然科学基金;
关键词
脂联素; 动脉粥样硬化; 冠心病;
D O I
10.13241/j.cnki.pmb.2008.03.038
中图分类号
R543.5 [动脉疾病];
学科分类号
摘要
脂肪细胞因子是心血管并发症的重要调节因子。其中,脂联素是脂肪细胞分泌的重要血管保护因子。肥胖、糖尿病及冠心痛患者脂联素水平显著降低,低脂联素血症是动脉粥样硬化发生发展的独立危险因素。脂联素既可直接抑制动脉粥样硬化灶的形成,亦可通过间接作用抑制动脉粥样硬化的形成。脂联素在动脉粥样硬化的防治方面有明显的应用前景。
引用
收藏
页码:576 / 579
页数:4
相关论文
共 23 条
[1]   Association of hypoadiponectinemia with impaired vasoreactivity [J].
Ouchi, N ;
Ohishi, M ;
Kihara, S ;
Funahashi, T ;
Nakamura, T ;
Nagaretani, H ;
Kumada, M ;
Ohashi, K ;
Okamoto, Y ;
Nishizawa, H ;
Kishida, K ;
Maeda, N ;
Nagasawa, A ;
Kobayashi, H ;
Hiraoka, H ;
Komai, N ;
Kaibe, M ;
Rakugi, H ;
Ogihara, T ;
Matsuzawa, Y .
HYPERTENSION, 2003, 42 (03) :231-234
[2]  
Role of ad iponectin in preven ting vascu lar stenosis. Them iss ing link of ad ipovascular axis. Matsuda M,Shimomura I,Sata M, et al. Journal of Biological Chemistry . 2002
[3]  
Heart[P]. 英国专利:GB0418877D0,2004-09-29
[4]  
Diabetes[P]. 英国专利:GB201117172D0,2011-11-16
[5]  
Adiponectin in patients with various stages of coronary heart disease comparison of its concentration in coronary arteries and peripheral venous circulation. Steiskal D,Bartek J. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub . 2003
[6]  
Increased expression of TNF-alpha,IL26 and IL28 in HALS:implications for reduced adiponectin expression and plasma-levels. Lihn AS,Ostergrd T,Nyholm B,et al. Am-J-Physiol- Endocri-nol Metab . 2003
[7]   Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease [J].
Ohashi, K ;
Ouchi, N ;
Kihara, S ;
Funahashi, T ;
Nakamura, T ;
Sumitsuji, S ;
Kawamoto, TK ;
Matsumoto, S ;
Nagaretani, H ;
Kumada, M ;
Okamoto, Y ;
Hiraoka, H ;
Iwashima, Y ;
Ishikawa, K ;
Ohishi, M ;
Katsuya, T ;
Rakugi, H ;
Ogihara, T ;
Matsuzawa, Y .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (07) :1195-1200
[8]  
Diabetes[P]. 英国专利:GB201117172D0,2011-11-16
[9]  
Globular adiponectin protectedob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. Yamauchi T,Kamon J,Waki H,Imai Y,Shimozawa N,Hioki K,Uchida S,Ito Y,TakakuwaK,Matsui J,Takata M,Eto K,Terauchi Y,Komeda K,Tsunoda M,Murakami K,Ohnishi Y,Naitoh T,Yamamura K,Ueyama Y,Froguel P,Kimura S,Nagai R,Kadowaki T. Journal of Biological Chemistry . 2003
[10]  
The adipocyte-secreted protein Acrp3 0 enhances hepatic insulin action. Berg A H, Combs T P, Du X, et al. Nature Medicine . 2001